PROTAGENIC THERAPEUTICS INC (PTIX)

US74365N2027 - Common Stock

1.75  -0.07 (-3.85%)

After market: 1.61 -0.14 (-8%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

PROTAGENIC THERAPEUTICS INC

NASDAQ:PTIX (3/28/2024, 8:00:01 PM)

After market: 1.61 -0.14 (-8%)

1.75

-0.07 (-3.85%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap7.77M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PTIX Daily chart

Company Profile

Protagenic Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in New York City, New York. The firm specializes in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Its lead compound is a 41-residue peptide synthetic TCAP-1. In addition, it has a portfolio of earlier stage neuropeptides targeting the TCAP pathway that are in preclinical evaluation. PT00114 has also demonstrated pre-clinical efficacy in a murine model of opioid withdrawal called the Saleens test. Its preclinical models have demonstrated the efficacy of PT00114 in animal models of depression, anxiety, substance abuse and addiction, and PTSD.

Company Info

PROTAGENIC THERAPEUTICS INC

149 Fifth Avenue, Suite 500

New York City NEW YORK 10010

P: 12129948200

CEO: Garo H. Armen

Employees: 0

Website: https://protagenic.com/

PTIX News

News Imagea year ago - Seeking AlphaProtagenic Therapeutics says board approved 1-for-4 reverse stock split (NASDAQ:PTIX)

Protagenic Therapeutics (PTIX) on Wednesday announced it has approved a 1-for-4 reverse stock split of the company's issued and outstanding common stock.

News Imagea year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

News Image2 years ago - Protagenic Therapeutics, Inc.Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

NEW YORK, NY / ACCESSWIRE / April 26, 2022 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, today announced will be presenting at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference tomorrow, April 27, 2022. The presentation details are as follows: Date: Wednesday, April 27, 2022 Time: 10:30 AM ET Link:

PTIX Twits

Here you can normally see the latest stock twits on PTIX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example